Myriad's BRCA Patents Not Only Illegal, but Also Unconstitutional, ACLU Lawsuit Alleges
May 13, 2009
Myriad's BRCA Patents Not Only Illegal, but Also Unconstitutional, ACLU Lawsuit Alleges
In the first US lawsuit of its kind, the ACLU is challenging gene patenting as an affront to First Amendment rights. Myriad Genetics, named in the lawsuit along with the USPTO and the University of Utah Research Foundation, said it plans to "vigorously defend" its BRCA patents.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Q&A: INMEGEN's Alfredo Hidalgo on Using Genomics to Address Mexico's Most Pressing Health Problems
May 17, 2013 / BioArray News - European Consortium Investigating Molecular Basis of IBD
May 17, 2013 / GenomeWeb Daily News - GMU Team Builds Phosphoproteomic-based Pathway Activation Profiles of NCI-60 Cancer Cell Lines
May 17, 2013 / ProteoMonitor - Vermillion Posts 8 Percent Increase in OVA1 Sales, Announces Shift in Commercialization Strategy
May 17, 2013 / ProteoMonitor - NIDDK to Fund Biomarker, Assay Projects Using Samples and Data from Its Repository
May 17, 2013 / GenomeWeb Daily News